Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression

Dirk Rades, Volker Rudat, Theo Veninga, Lukas J A Stalpers, Peter J. Hoskin, Steven E. Schild

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

BACKGROUND. The purpose of the current study was to retrospectively investigate clinical outcome and potential prognostic factors after reirradiation (Re-RT) for in-field recurrence of metastatic spinal cord compression (MSCC). METHODS. Re-RT with 1 x 8 Gy (n = 48), 5 x 3 Gy (n = 29), 5 x 4 Gy (n = 30), 7 x 3 Gy (n = 3), 10-12 x 2 Gy (n = 11), or 17 x 1.8 Gy (n = 3) was administered to 124 patients. Cumulative biologically effective dose (BED) (first course of RT plus re-RT) ranged from 77.5 Gy2 to 142.6 Gy 2, and was ≤ 120 Gy2 in 114 (92%) patients. Twelve potential prognostic factors were investigated for associations with motor function and survival. RESULTS. Motor function improved in 45 (36%) patients, was stable in another 62 (50%) patients, and deteriorated in 17 (14%) patients. Upon multivariate analyses, the effect of Re-RT on motor function was significantly associated with the effect of the first course of RT (P = .048), Eastern Cooperative Oncology Group (ECOG) performance status (P = .020), time to development of motor deficits before Re-RT (P = .002), and visceral metastases (P < .001). Survival was associated with ECOG performance status (P < .001), ambulatory status before Re-RT (P < .001), time to development of motor deficits (P = .018), and visceral metastases (P < .001). Re-RT dose schedule or cumulative BED had no significant impact on functional outcome or survival. Acute toxicity was mild, and late toxicity, such as radiation myelopathy, was not observed. CONCLUSIONS. Given the limitations of a retrospective study and the relatively short follow up after Re-RT, spinal reirradiation appeared to be effective and safe when the cumulative BED is ≤ 120 Gy2. Motor function after Re-RT was associated with the effect of first irradiation, performance status, time to development of motor deficits, and visceral metastases, whereas the Re-RT schedule had no significant impact.

Original languageEnglish (US)
Pages (from-to)1090-1096
Number of pages7
JournalCancer
Volume113
Issue number5
DOIs
StatePublished - Sep 1 2008

Fingerprint

Spinal Cord Compression
Recurrence
Survival
Neoplasm Metastasis
Appointments and Schedules
Re-Irradiation
Spinal Cord Diseases
Multivariate Analysis
Retrospective Studies
Radiation

Keywords

  • Metastatic spinal cord compression
  • Motor function
  • Prognostic factors
  • Spinal reirradiation
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. / Rades, Dirk; Rudat, Volker; Veninga, Theo; Stalpers, Lukas J A; Hoskin, Peter J.; Schild, Steven E.

In: Cancer, Vol. 113, No. 5, 01.09.2008, p. 1090-1096.

Research output: Contribution to journalArticle

Rades, Dirk ; Rudat, Volker ; Veninga, Theo ; Stalpers, Lukas J A ; Hoskin, Peter J. ; Schild, Steven E. / Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. In: Cancer. 2008 ; Vol. 113, No. 5. pp. 1090-1096.
@article{0c0781a4597548349240cf63f803e723,
title = "Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression",
abstract = "BACKGROUND. The purpose of the current study was to retrospectively investigate clinical outcome and potential prognostic factors after reirradiation (Re-RT) for in-field recurrence of metastatic spinal cord compression (MSCC). METHODS. Re-RT with 1 x 8 Gy (n = 48), 5 x 3 Gy (n = 29), 5 x 4 Gy (n = 30), 7 x 3 Gy (n = 3), 10-12 x 2 Gy (n = 11), or 17 x 1.8 Gy (n = 3) was administered to 124 patients. Cumulative biologically effective dose (BED) (first course of RT plus re-RT) ranged from 77.5 Gy2 to 142.6 Gy 2, and was ≤ 120 Gy2 in 114 (92{\%}) patients. Twelve potential prognostic factors were investigated for associations with motor function and survival. RESULTS. Motor function improved in 45 (36{\%}) patients, was stable in another 62 (50{\%}) patients, and deteriorated in 17 (14{\%}) patients. Upon multivariate analyses, the effect of Re-RT on motor function was significantly associated with the effect of the first course of RT (P = .048), Eastern Cooperative Oncology Group (ECOG) performance status (P = .020), time to development of motor deficits before Re-RT (P = .002), and visceral metastases (P < .001). Survival was associated with ECOG performance status (P < .001), ambulatory status before Re-RT (P < .001), time to development of motor deficits (P = .018), and visceral metastases (P < .001). Re-RT dose schedule or cumulative BED had no significant impact on functional outcome or survival. Acute toxicity was mild, and late toxicity, such as radiation myelopathy, was not observed. CONCLUSIONS. Given the limitations of a retrospective study and the relatively short follow up after Re-RT, spinal reirradiation appeared to be effective and safe when the cumulative BED is ≤ 120 Gy2. Motor function after Re-RT was associated with the effect of first irradiation, performance status, time to development of motor deficits, and visceral metastases, whereas the Re-RT schedule had no significant impact.",
keywords = "Metastatic spinal cord compression, Motor function, Prognostic factors, Spinal reirradiation, Survival",
author = "Dirk Rades and Volker Rudat and Theo Veninga and Stalpers, {Lukas J A} and Hoskin, {Peter J.} and Schild, {Steven E.}",
year = "2008",
month = "9",
day = "1",
doi = "10.1002/cncr.23702",
language = "English (US)",
volume = "113",
pages = "1090--1096",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression

AU - Rades, Dirk

AU - Rudat, Volker

AU - Veninga, Theo

AU - Stalpers, Lukas J A

AU - Hoskin, Peter J.

AU - Schild, Steven E.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - BACKGROUND. The purpose of the current study was to retrospectively investigate clinical outcome and potential prognostic factors after reirradiation (Re-RT) for in-field recurrence of metastatic spinal cord compression (MSCC). METHODS. Re-RT with 1 x 8 Gy (n = 48), 5 x 3 Gy (n = 29), 5 x 4 Gy (n = 30), 7 x 3 Gy (n = 3), 10-12 x 2 Gy (n = 11), or 17 x 1.8 Gy (n = 3) was administered to 124 patients. Cumulative biologically effective dose (BED) (first course of RT plus re-RT) ranged from 77.5 Gy2 to 142.6 Gy 2, and was ≤ 120 Gy2 in 114 (92%) patients. Twelve potential prognostic factors were investigated for associations with motor function and survival. RESULTS. Motor function improved in 45 (36%) patients, was stable in another 62 (50%) patients, and deteriorated in 17 (14%) patients. Upon multivariate analyses, the effect of Re-RT on motor function was significantly associated with the effect of the first course of RT (P = .048), Eastern Cooperative Oncology Group (ECOG) performance status (P = .020), time to development of motor deficits before Re-RT (P = .002), and visceral metastases (P < .001). Survival was associated with ECOG performance status (P < .001), ambulatory status before Re-RT (P < .001), time to development of motor deficits (P = .018), and visceral metastases (P < .001). Re-RT dose schedule or cumulative BED had no significant impact on functional outcome or survival. Acute toxicity was mild, and late toxicity, such as radiation myelopathy, was not observed. CONCLUSIONS. Given the limitations of a retrospective study and the relatively short follow up after Re-RT, spinal reirradiation appeared to be effective and safe when the cumulative BED is ≤ 120 Gy2. Motor function after Re-RT was associated with the effect of first irradiation, performance status, time to development of motor deficits, and visceral metastases, whereas the Re-RT schedule had no significant impact.

AB - BACKGROUND. The purpose of the current study was to retrospectively investigate clinical outcome and potential prognostic factors after reirradiation (Re-RT) for in-field recurrence of metastatic spinal cord compression (MSCC). METHODS. Re-RT with 1 x 8 Gy (n = 48), 5 x 3 Gy (n = 29), 5 x 4 Gy (n = 30), 7 x 3 Gy (n = 3), 10-12 x 2 Gy (n = 11), or 17 x 1.8 Gy (n = 3) was administered to 124 patients. Cumulative biologically effective dose (BED) (first course of RT plus re-RT) ranged from 77.5 Gy2 to 142.6 Gy 2, and was ≤ 120 Gy2 in 114 (92%) patients. Twelve potential prognostic factors were investigated for associations with motor function and survival. RESULTS. Motor function improved in 45 (36%) patients, was stable in another 62 (50%) patients, and deteriorated in 17 (14%) patients. Upon multivariate analyses, the effect of Re-RT on motor function was significantly associated with the effect of the first course of RT (P = .048), Eastern Cooperative Oncology Group (ECOG) performance status (P = .020), time to development of motor deficits before Re-RT (P = .002), and visceral metastases (P < .001). Survival was associated with ECOG performance status (P < .001), ambulatory status before Re-RT (P < .001), time to development of motor deficits (P = .018), and visceral metastases (P < .001). Re-RT dose schedule or cumulative BED had no significant impact on functional outcome or survival. Acute toxicity was mild, and late toxicity, such as radiation myelopathy, was not observed. CONCLUSIONS. Given the limitations of a retrospective study and the relatively short follow up after Re-RT, spinal reirradiation appeared to be effective and safe when the cumulative BED is ≤ 120 Gy2. Motor function after Re-RT was associated with the effect of first irradiation, performance status, time to development of motor deficits, and visceral metastases, whereas the Re-RT schedule had no significant impact.

KW - Metastatic spinal cord compression

KW - Motor function

KW - Prognostic factors

KW - Spinal reirradiation

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=52049117472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049117472&partnerID=8YFLogxK

U2 - 10.1002/cncr.23702

DO - 10.1002/cncr.23702

M3 - Article

C2 - 18642349

AN - SCOPUS:52049117472

VL - 113

SP - 1090

EP - 1096

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -